Contents

Current Medicinal Chemistry, Volume 21 - Number 35

System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening

, 21(35): 3985 - 3998

Juan Sebastian Yakisich


DOI: 10.2174/09298673113209990009




Association Between Polycystic Ovary Syndrome and Metabolic Syndrome

, 21(35): 3999 - 4012

Leandro Martin Velez and Alicia Beatriz Motta


DOI: 10.2174/0929867321666140915141030




Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective

, 21(35): 4013 - 4045

R.N. Kushwaha, W. Haq and S.B. Katti


DOI: 10.2174/0929867321666140915143309




Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

, 21(35): 4046 - 4058

Federico Carbone, Francois Mach, Nicolas Vuilleumier and Fabrizio Montecucco


DOI: 10.2174/0929867321666140915141332




Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment

, 21(35): 4059 - 4073

P. Skupin-Mrugalska, L. Sobotta, M. Kucinska, M. Murias, J. Mielcarek and N. Duzgunes


DOI: 10.2174/0929867321666140826120300




α-Glucan Pathway as a Novel Mtb Drug Target: Structural Insights and Cues for Polypharmcological Targeting of GlgB and GlgE

, 21(35): 4074 - 4084

Pushpa Agrawal, Pawan Gupta, Kunchithapadam Swaminathan and Raman Parkesh


DOI: 10.2174/0929867321666140826120449




Clearance of Beta-Amyloid in the Brain

, 21(35): 4085 - 4090

Masaki Ueno, Yoichi Chiba, Koichi Matsumoto, Toshitaka Nakagawa and Hiroshi Miyanaka


DOI: 10.2174/0929867321666141011194256




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science